Fulgent Genetics, Inc. FLGT Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $322.67M+13.8% | $283.47M-2.0% | $289.21M-53.3% | $618.97M-37.6% | ||
| $191.8M+8.8% | $176.26M-4.6% | $184.76M-26.7% | $252.07M+17.0% | ||
| $130.88M+22.1% | $107.22M+2.6% | $104.46M-71.5% | $366.9M-52.8% | ||
| 40.6%+2.7pp | 37.8%+1.7pp | 36.1%-23.2pp | 59.3%-19.0pp | ||
| $53.91M+10.4% | $48.82M+17.8% | $41.44M+43.3% | $28.91M+19.4% | ||
| $43.37M+19.7% | $36.25M-12.6% | $41.47M+6.5% | $38.92M+59.2% | ||
| $116.66M+32.4% | $88.11M-1.0% | $89M-19.9% | $111.07M+119% | ||
| $221.97M+22.5% | $181.13M-39.6% | $299.99M+59.2% | $188.37M+86.3% | ||
| -$91.1M-23.2% | -$73.92M+62.2% | -$195.53M-210% | $178.53M-73.6% | ||
| -28.2%-2.2pp | -26.1%+41.5pp | -67.6%-96.4pp | 28.8%-39.3pp | ||
| $75K— | —— | —— | $1.01M— | ||
| $21.07M-4.0% | $21.95M— | —— | $5.5M— | ||
| -$70.03M-34.8% | -$51.96M+70.2% | -$174.09M-195% | $184.03M-72.8% | ||
| -$8.39M-3.1% | -$8.14M— | —— | $42.1M-75.9% | ||
| -$60.51M-41.7% | -$42.71M+74.6% | -$167.83M-217% | $143.4M-71.7% | ||
| -18.8%-3.7pp | -15.1%+43.0pp | -58%-81.2pp | 23.2%-27.9pp | ||
| -$1.96-39.0% | -$1.41+75.0% | -$5.64-224% | $4.56-72.2% | ||
| -$66.97M-36.7% | -$48.99M+71.1% | -$169.39M-180% | $211.19M-69.3% | ||
| -20.8%-3.5pp | -17.3%+41.3pp | -58.6%-92.7pp | 34.1%-35.1pp | ||
| -$91.1M-23.2% | -$73.92M+62.2% | -$195.53M-210% | $178.53M-73.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Fulgent Genetics, Inc.'s revenue?
- Fulgent Genetics, Inc. (FLGT) generated $320.3M in revenue over the trailing twelve months, up 9.5% year over year.
- Is Fulgent Genetics, Inc. profitable?
- Fulgent Genetics, Inc. is not currently profitable: it reported a net loss of $73.8M over the trailing twelve months, a -23.0% net margin.
- What are Fulgent Genetics, Inc.'s profit margins?
- Gross margin is 38.7% and operating margin is -33.1%, with a -23.0% net margin.
- What is Fulgent Genetics, Inc.'s earnings per share?
- Fulgent Genetics, Inc.'s diluted EPS over the trailing twelve months is $-2.39.
- Where does Fulgent Genetics, Inc.'s income statement data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
